• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异喹啉磺酰胺类蛋白激酶抑制剂选择性的结构基础。

Structural basis for selectivity of the isoquinoline sulfonamide family of protein kinase inhibitors.

作者信息

Xu R M, Carmel G, Kuret J, Cheng X

机构信息

W.M. Keck Structural Biology Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.

出版信息

Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6308-13. doi: 10.1073/pnas.93.13.6308.

DOI:10.1073/pnas.93.13.6308
PMID:8692811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC39018/
Abstract

A large family of isoquinoline sulfonamide compounds inhibits protein kinases by competing with adenosine triphosphates(ATP), yet interferes little with the activity of other ATP-using enzymes such as ATPases and adenylate cyclases. One such compound, N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide (CK17), is selective for casein kinase-1 isolated from a variety of sources. Here we report the crystal structure of the catalytic domain of Schizosaccharomyces pombe casein kinase-1 complexed with CK17, refined to a crystallographic R-factor of 17.8% at 2.5 angstrom resolution. The structure provides new insights into the mechanism of the ATP-competing inhibition and the origin of their selectivity toward different protein kinases. Selectivity for protein kinases versus other enzymes is achieved by hydrophobic contacts and the hydrogen bond with isoquinoline ring. We propose that the hydrogen bond involving the ring nitrogen-2 atom of the isoquinoline must be preserved, but that the ring can flip depending on the chemical substituents at ring positions 5 and 8. Selectivity for individual members of the protein kinase family is achieved primarily by interactions with these substituents.

摘要

一大类异喹啉磺酰胺化合物通过与三磷酸腺苷(ATP)竞争来抑制蛋白激酶,但对其他利用ATP的酶(如ATP酶和腺苷酸环化酶)的活性影响很小。其中一种化合物,N-(2-氨基乙基)-5-氯异喹啉-8-磺酰胺(CK17),对从多种来源分离得到的酪蛋白激酶-1具有选择性。在此我们报道了粟酒裂殖酵母酪蛋白激酶-1催化结构域与CK17复合物的晶体结构,在2.5埃分辨率下精修至晶体学R因子为17.8%。该结构为ATP竞争抑制机制以及它们对不同蛋白激酶选择性的起源提供了新的见解。对蛋白激酶与其他酶的选择性是通过疏水接触以及与异喹啉环的氢键实现的。我们提出涉及异喹啉环氮-2原子的氢键必须得以保留,但环可以根据环上5位和8位的化学取代基翻转。对蛋白激酶家族中各个成员的选择性主要是通过与这些取代基的相互作用来实现的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/374a/39018/24366cf4206d/pnas01517-0109-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/374a/39018/1041f913c6e2/pnas01517-0106-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/374a/39018/24366cf4206d/pnas01517-0109-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/374a/39018/1041f913c6e2/pnas01517-0106-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/374a/39018/24366cf4206d/pnas01517-0109-a.jpg

相似文献

1
Structural basis for selectivity of the isoquinoline sulfonamide family of protein kinase inhibitors.异喹啉磺酰胺类蛋白激酶抑制剂选择性的结构基础。
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6308-13. doi: 10.1073/pnas.93.13.6308.
2
Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity.环磷酸腺苷依赖性蛋白激酶催化亚基与异喹啉磺酰蛋白激酶抑制剂H7、H8和H89复合物的晶体结构。选择性的结构意义。
J Biol Chem. 1996 Oct 18;271(42):26157-64. doi: 10.1074/jbc.271.42.26157.
3
Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide.用于正电子发射断层扫描的合理设计的蛋白激酶A抑制剂:N-(2-(4-溴肉桂氨基)乙基)-N-[11C]甲基异喹啉-5-磺酰胺的合成与脑内生物分布
Bioorg Med Chem. 2008 May 1;16(9):5277-84. doi: 10.1016/j.bmc.2008.03.013. Epub 2008 Mar 6.
4
Design of potent protein kinase inhibitors using the bisubstrate approach.采用双底物方法设计强效蛋白激酶抑制剂。
J Med Chem. 1991 Jan;34(1):73-8. doi: 10.1021/jm00105a012.
5
Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.基于结构的蛋白激酶B的异喹啉-5-磺酰胺抑制剂设计
Bioorg Med Chem. 2006 Feb 15;14(4):1255-73. doi: 10.1016/j.bmc.2005.09.055. Epub 2005 Oct 24.
6
Crystal structure of a conformation-selective casein kinase-1 inhibitor.一种构象选择性酪蛋白激酶-1抑制剂的晶体结构
J Biol Chem. 2000 Jun 30;275(26):20052-60. doi: 10.1074/jbc.M001713200.
7
Effects of rigidity on the selectivity of protein kinase inhibitors.刚性对蛋白激酶抑制剂选择性的影响。
Eur J Med Chem. 2018 Feb 25;146:519-528. doi: 10.1016/j.ejmech.2018.01.053. Epub 2018 Jan 31.
8
Selective inhibition of cyclic AMP-dependent protein kinase by isoquinoline derivatives.异喹啉衍生物对环磷酸腺苷依赖性蛋白激酶的选择性抑制作用。
Biol Chem Hoppe Seyler. 1996 Jun;377(6):373-84. doi: 10.1515/bchm3.1996.377.6.373.
9
Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity.新型Chk1抑制剂的基于结构的设计:对氢键和蛋白质-配体亲和力的见解
J Med Chem. 2005 Jun 30;48(13):4332-45. doi: 10.1021/jm049022c.
10
Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine.与肽抑制剂PKI(5 - 24)和腺苷复合的环磷酸腺苷依赖性蛋白激酶的多组氨酸标签重组催化亚基的晶体结构。
Biochemistry. 1997 Apr 15;36(15):4438-48. doi: 10.1021/bi961947+.

引用本文的文献

1
The protein kinase CK1: Inhibition, activation, and possible allosteric modulation.蛋白激酶CK1:抑制、激活及可能的别构调节
Front Mol Biosci. 2022 Aug 24;9:916232. doi: 10.3389/fmolb.2022.916232. eCollection 2022.
2
Cell Therapy for Retinal Dystrophies: From Cell Suspension Formulation to Complex Retinal Tissue Bioengineering.视网膜营养不良的细胞疗法:从细胞悬液制剂到复杂视网膜组织生物工程
Stem Cells Int. 2019 Jan 23;2019:4568979. doi: 10.1155/2019/4568979. eCollection 2019.
3
Structure of the Saccharomyces cerevisiae Hrr25:Mam1 monopolin subcomplex reveals a novel kinase regulator.

本文引用的文献

1
Crystal structure of cyclin-dependent kinase 2.细胞周期蛋白依赖性激酶2的晶体结构
Nature. 1993 Jun 17;363(6430):595-602. doi: 10.1038/363595a0.
2
Experimental resolution of the free energies of aqueous solvation contributions to ligand-protein binding: quinone-QA site interactions in the photosynthetic reaction center protein.水合溶剂化对配体-蛋白质结合贡献的自由能的实验解析:光合反应中心蛋白中的醌-QA位点相互作用
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2920-4. doi: 10.1073/pnas.90.7.2920.
3
Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor.
酿酒酵母Hrr25:Mam1单极蛋白亚复合物的结构揭示了一种新型激酶调节剂。
EMBO J. 2016 Oct 4;35(19):2139-2151. doi: 10.15252/embj.201694082. Epub 2016 Aug 4.
4
Crystal structures of two aminoglycoside kinases bound with a eukaryotic protein kinase inhibitor.两种氨基糖苷激酶与真核蛋白激酶抑制剂结合的晶体结构。
PLoS One. 2011 May 9;6(5):e19589. doi: 10.1371/journal.pone.0019589.
5
Crystal structure of inhibitor of κB kinase β.κB 激酶 β 抑制剂的晶体结构。
Nature. 2011 Apr 21;472(7343):325-30. doi: 10.1038/nature09853. Epub 2011 Mar 20.
6
Synthesis of polymer-bound 4-acetoxy-3-phenylbenzaldehyde derivatives: applications in solid-phase organic synthesis.聚合物键合的4-乙酰氧基-3-苯基苯甲醛衍生物的合成:在固相有机合成中的应用。
J Org Chem. 2006 Sep 29;71(20):7915-8. doi: 10.1021/jo061328z.
7
Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors.代谢型谷氨酸受体对细胞周期蛋白依赖性激酶5和酪蛋白激酶1的调控。
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11062-8. doi: 10.1073/pnas.191353898.
8
The AP-3 complex required for endosomal synaptic vesicle biogenesis is associated with a casein kinase Ialpha-like isoform.内体性突触小泡生物发生所需的AP-3复合物与一种酪蛋白激酶Iα样亚型相关。
Mol Biol Cell. 2000 Aug;11(8):2591-604. doi: 10.1091/mbc.11.8.2591.
与MgATP和肽抑制剂复合的环磷酸腺苷依赖性蛋白激酶催化亚基的晶体结构。
Biochemistry. 1993 Mar 9;32(9):2154-61. doi: 10.1021/bi00060a005.
4
Control of simian virus 40 DNA replication by the HeLa cell nuclear kinase casein kinase I.海拉细胞核激酶酪蛋白激酶I对猿猴病毒40 DNA复制的调控
Mol Cell Biol. 1993 Feb;13(2):1202-11. doi: 10.1128/mcb.13.2.1202-1211.1993.
5
Casein kinases: pleiotropic mediators of cellular regulation.酪蛋白激酶:细胞调节的多效性介质
Pharmacol Ther. 1993;59(1):1-30. doi: 10.1016/0163-7258(93)90039-g.
6
Cytoplasmic forms of fission yeast casein kinase-1 associate primarily with the particulate fraction of the cell.裂殖酵母酪蛋白激酶-1的细胞质形式主要与细胞的颗粒部分相关联。
J Biol Chem. 1994 Apr 22;269(16):12014-23.
7
Expression, purification, crystallization, and preliminary x-ray analysis of casein kinase-1 from Schizosaccharomyces pombe.
J Biol Chem. 1994 Mar 11;269(10):7304-9.
8
Atomic structure of the MAP kinase ERK2 at 2.3 A resolution.丝裂原活化蛋白激酶ERK2在2.3埃分辨率下的原子结构。
Nature. 1994 Feb 24;367(6465):704-11. doi: 10.1038/367704a0.
9
Crystal structure of casein kinase-1, a phosphate-directed protein kinase.酪蛋白激酶-1(一种磷酸定向蛋白激酶)的晶体结构
EMBO J. 1995 Mar 1;14(5):1015-23. doi: 10.1002/j.1460-2075.1995.tb07082.x.
10
Two structures of the catalytic domain of phosphorylase kinase: an active protein kinase complexed with substrate analogue and product.磷酸化酶激酶催化结构域的两种结构:一种与底物类似物和产物复合的活性蛋白激酶。
Structure. 1995 May 15;3(5):467-82. doi: 10.1016/s0969-2126(01)00180-0.